Clinical Trial

SMC Radiation Oncology Breast Cancer Cohort Study

Study acronym: RASCO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about toxicities and cosmetic outcomes in breast cancer patients treated with hypofractionated radiotherapy. The main question it aims to answer are: * Changes in breast skin * Factors related to breast skin changes * Patient-reported outcomes * Cosmetic outcomes Participants will be assessed by multi-dimensional methods before and after radiotherapy: * Photographs * Fibrometer * Questionnaires (BREAST-Q) * CTCAE version 4.03 evaluated by treating physicians
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-08-11
notable Primary completion pushed: 2025-12-31 -> 2030-12-31 2026-08-11
Trial Details
NCT Number NCT05775757
Lead Sponsor Samsung Medical Center
Conditions Radiotherapy Side Effect
Enrollment 500 participants
Start Date 2021-01-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10